Compounding Pharmacies Market to Grow at Stellar CAGR 6% During the Forecast Period 2021

30/giu/2020 12:47:47 persistencemarketresearch Contatta l'autore

Questo comunicato è stato pubblicato più di 30 giorni fa. Le informazioni su questa pagina potrebbero non essere attendibili.

New York City, United States -  The change during the COVID-19 pandemic has overhauled our dependence on pattern setting developments, for instance, expanded reality, computer generated reality, and the Healthcare web of things. The unfulfilled cash related targets are persuading the relationship to grasp robotization and forefront advancements to stay ahead in the market competition. Associations are utilizing this open entryway by recognizing step by step operational needs and showing robotization in it to make an automated structure as far as might be feasible.

 

Compounding pharmacies are one of the growing trends in the health industry owing to the rise in aging population and increasing prevalence of chronic diseases. Compounding pharmacies play an important role in the testing and development of drugs.

Compounding pharmacists are currently involved in testing and development of new drug formulations to ensure the safety of the drug for patients. Pharmaceutical companies and physicians are focusing on compounding pharmacies to introduce new drugs in the market and also to recreate commercially available drugs with new formulations.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/5270

Company Profiles

  • B. Braun Melsungen AG Company.
  • Fagron.
  • PharMEDium Services, LLC.
  • Institutional Pharmacy Solutions.
  • Cantrell Drug Company.
  • Triangle Compounding Pharmacies.
  • Lorraine’s Pharmacy.
  • Fresenius Kabi AG

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/5270

Increasing number of patients with special pharmaceutical needs are driving the growth of the global compounding pharmacies market. Compounding pharmacies are also focusing on sterile composition. This calls for in-depth knowledge on medication in order to select the most suitable components while preparing the medicines. Women’s health, dermatology, pediatrics, and sports medicine are adopting sterile compounding to offer the perfect combination of medications.

However, owing to the cases of contaminated prescriptions is emerging as a challenge in the compounding pharmacies. The regulatory bodies are also focusing on introducing stringent regulation on the compounding pharmacies. Meanwhile, lack of skilled professionals is resulting in the increased risk of producing improper compounded medicines.

As per the study by Persistence Market Research (PMR), the global compounding pharmacies market is expected to see a strong growth during 2017-2025. By the end of 2025, the global market for compounding pharmacies is estimated to exceed US$ 13,300 Million in terms of revenue.

Oral Medication to be Highly Preferred in the Global Compounding Pharmacies Market

On the basis of product type, oral medication including tablets, capsules, lollipops, mixtures, and lozenges are likely to witness the highest growth during 2017-2025. Oral medication is projected to surpass US$ 6,300 Million revenue by 2025 end.

Based on the application, compounding pharmacy products are expected to find large application in medication for adults, followed by medication for children. By 2025 end, medication for adults is estimated to bring in close to US$ 7,600 Million revenue.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/5270

By therapeutic area, compounding pharmacy products are likely to be largely used in hormone replacement therapy. Towards 2025 end, hormone replacement therapy is projected to reach nearly US$ 9,400 Million in terms of value.

North America to Account for the Highest Share in the Global Compounding Pharmacies Market

During the forecast period 2017-2025, North America is expected to lead the global market for compounding pharmacies. By the end of 2025, North America is estimated to exceed US$ 8,900 Million revenue. The Food and Drug Administration (FDA) is increasing regulations on the compounding pharmacies.

Moreover, healthcare providers are also increasingly buying compounded medicines from FDA registered facilities. As per the data by Pharmaceutical Research and Manufacturers of America (PhRMA), around 3.6 billion prescriptions are distributed in the U.S. every year.

Moreover, increasing number of people in North America are also suffering from allergies, this is also driving the demand for compounded pharmaceuticals. However, the high cost of generating drugs, lack of awareness, and failure of companies to comply with FDA standards are some of the challenges in the compounding pharmacies market in North America.

Explore Extensive Coverage of PMR`s Life Sciences & Transformational Health Landscape

Feminine Hygiene Product Market – Feminine Hygiene Products Market Segmented By Sanitary Pads/Napkins, Tampons, Panty Liners, Menstrual Cups, and Feminine Hygiene Wash. For More Information

Elder Care Services Market  - Elder Care Services Market Segmented By Home-based Care, Community-based Care, Institutional Care Services and Financing Source By Public Expenditure, Private Source, Out-of-Pocket Spending. For More Information

 
About us:

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and  market research methodology  to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Our client success stories feature a range of clients from Fortune 500 companies to fast-growing startups. PMR's collaborative environment is committed to building industry-specific solutions by transforming data from multiple streams into a strategic asset.

Contact us:

Ashish Kolte
Persistence Market Research
Address - 305 Broadway, 7th FloorNew York City,
NY 10007 United States
U.S. Ph. - + 1-646-568-7751
USA-Canada Toll-free - +1 800-961-0353
Sales  -  sales@persistencemarketresearch.com
Website  -  https://www.persistencemarketresearch.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl